Invention Grant
- Patent Title: Bioerodible silicon-based devices for delivery of therapeutic agents
-
Application No.: US15147203Application Date: 2016-05-05
-
Publication No.: US11026885B2Publication Date: 2021-06-08
- Inventor: Paul Ashton , Leigh T. Canham , Christian Barnett
- Applicant: Paul Ashton , Leigh T. Canham , Christian Barnett
- Applicant Address: US MA Newton; GB Malvern; GB Pershore
- Assignee: Paul Ashton,Leigh T. Canham,Christian Barnett
- Current Assignee: Paul Ashton,Leigh T. Canham,Christian Barnett
- Current Assignee Address: US MA Newton; GB Malvern; GB Pershore
- Agency: Hogan Lovells US LLP
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/14 ; A61K38/17 ; A61K38/28 ; A61K38/47 ; A61L27/02 ; A61L27/54 ; A61L27/56 ; C07K16/22 ; A61K39/395

Abstract:
This invention discloses bioerodible devices, such as implants for delivering therapeutic agents, particularly large molecules such as proteins and antibodies, in a controlled manner. The devices comprise a porous silicon-based carrier material impregnated with the therapeutic agent. The device may be used in vitro or in vivo to deliver the therapeutic agent, preferably in a controlled fashion over an intended period of time such as over multiple days, weeks or months. The device may be used for treating or preventing conditions of a patient such as chronic diseases.
Public/Granted literature
- US20160243276A1 BIOERODIBLE SILICON-BASED DEVICES FOR DELIVERY OF THERAPEUTIC AGENTS Public/Granted day:2016-08-25
Information query